2010 Annual Meeting | Advanced Topics in Pediatric Neurology I: Neurodegenerative Diseases
09:00 AM - 09:40 AM |
Spinal Muscular Atrophy
Basil T. Darras, MD |
|
09:40 AM - 09:50 AM |
Questions and Answers
Basil T. Darras, MD |
|
09:50 AM - 10:30 AM |
Neuronal Ceroid Lipofuscinoses (Batten Disease)
Jonathan W. Mink, MD, PhD, FAAN |
|
10:30 AM - 10:40 AM |
Questions and Answers
Jonathan W. Mink, MD, PhD, FAAN |
|
10:40 AM - 10:55 AM |
Break
|
|
10:55 AM - 11:35 AM |
Niemann Pick Disease Type C and Related Disorders
Marc C. Patterson, MD, FRACP, FAAN |
|
11:35 AM - 11:45 AM |
Questions and Answers
Marc C. Patterson, MD, FRACP, FAAN |
|
11:45 AM - 12:25 PM |
Neurodegeneration with Brain Iron Accumulation including Pantothenate Kinase-Associated Neurodegeneration
Susan J. Hayflick, MD, PhD |
|
12:25 PM - 12:35 PM |
Questions and Answers
Susan J. Hayflick, MD, PhD |
|
12:35 PM - 12:45 PM |
Discussion
|
Basil T. Darras, MD | The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care. |
Jonathan W. Mink, MD, PhD, FAAN | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
Marc C. Patterson, MD, FRACP, FAAN | The institution of Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme /KemPharm/Zevra. Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azafaros. Dr. Patterson has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. Dr. Patterson has stock in IntraBio. The institution of Dr. Patterson has received research support from Glycomine. The institution of Dr. Patterson has received research support from Orphazyme /KemPharm/Zevra. The institution of Dr. Patterson has received research support from Idorsia. The institution of Dr. Patterson has received research support from Shire-Takeda. Dr. Patterson has received publishing royalties from a publication relating to health care. Dr. Patterson has received publishing royalties from a publication relating to health care. |
Susan J. Hayflick, MD, PhD | An immediate family member of Susan J. Hayflick, MD, PhD has received personal compensation for serving as an employee of AbVie. The institution of Susan J. Hayflick, MD, PhD has received research support from NIH. The institution of an immediate family member of Susan J. Hayflick, MD, PhD has received research support from NIH. |